美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

艾格里房产

74.41

+0.01000.01%

盘后：74.410.00000.00%19:13 EDT

成交量：94.57万

成交额：7,054.69万

市值：89.31亿

市盈率：42.04

高：75.33

开：74.40

低：74.03

收：74.40

52周最高：82.08

52周最低：68.98

股本：1.20亿

流通股本：1.08亿

量比：0.57

换手率：0.87%

股息：3.08

股息率：4.14%

每股收益(TTM):1.77

每股收益(LYR):1.77

净资产收益率：3.48%

总资产收益率：2.37%

市净率：1.47

市盈率(LYR):42.04

数据加载中...

总览公司新闻资讯公告

开发下一代 ADC，新锐融资1.2亿美元，默沙东支持

中国生物制药(01177)：LM-350“CDH17 ADC”临床试验申请获NMPA批准

历史性突破！“中国智造”ADC新药全球首个取得食管癌III期临床研究成功

攻克耗能黑洞，下一代AI硬件系统能耗锐减57.2%

睿智医药发布全球首台ADC和核苷酸单体药物智造系统

港股上市七个月，映恩生物启动回A计划上半年亏逾20亿元，创始人高年薪受关注

深圳商报·读创

特朗普“降药价”新政下，中国药企谁是赢家？

ADC Therapeutics 2025财年Q3业绩会总结及问答精华：ZENLATA临床进展与市场扩展潜力

业绩会速递

【券商聚焦】中泰国际重申信达生物(01801)“买入”评级指武田加盟将夯实公司在IO与ADC领域研发能力

吉利德：Trop2 ADC一线治疗HR+/HER2-乳腺三期临床失败

复宏汉霖PD-L1 ADC肺癌新药发布关键数据，CEO朱俊：定位PD-1 联用的super ADC

PD-L1 ADC肺癌数据积极复宏汉霖HLX43迎关键节点与资金考验

每日经济新闻

百利天恒(688506.SH)：T-Bren(HER2 ADC)用于HER2阳性局部晚期或转移性胃或胃食管结合部腺癌患者纳入突破性治疗品种名单

全球肺癌治疗版图重构：本土创新药企凭ADC与双抗技术从“跟跑”转向“并跑”，复宏汉霖等公司国际化战略加速推进

华夏时报网

【券商聚焦】兴业证券维持翰森制药(03692)“买入”评级指其ADC平台研发实力强

【券商聚焦】信达证券首予维立志博(09887)“买入”评级指ADC平台未来可期

海峡西岸概念再度上演涨停潮：下周机会如何把握？

新股消息 | 百力司康拟港股上市中国证监会要求补充说明公司经营管理的实际运作等情况

高盛：下一代IO-ADC有望引领复宏汉霖(02696)全球化管线布局首予“买入”评级目标价100.70港元

身价超越宗馥莉，中国新晋女首富什么来头？

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ADC/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房产","latestPrice":74.41,"timestamp":1774641600000,"preClose":74.4,"halted":0,"volume":945681,"hourTrading":{"tag":"盘后","latestPrice":74.41,"preClose":74.41,"latestTime":"19:13 EDT","volume":39037,"amount":2904746.17,"timestamp":1774653235681,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0001344086021504154,"floatShares":108366822,"shares":120028300,"eps":1.77,"marketStatus":"休市中","change":0.01,"latestTime":"03-27 16:00:00 EDT","open":74.4,"high":75.33,"low":74.03,"amount":70546904.20305,"amplitude":0.017473,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.77,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":74.4,"dividendRate":0.041406,"preHourTrading":{"tag":"盘前","latestPrice":74.4,"preClose":74.4,"latestTime":"08:03 EDT","volume":7,"amount":531.45001,"timestamp":1774612986754,"change":0,"changeRate":0,"amplitude":0.028629},"postHourTrading":{"tag":"盘后","latestPrice":74.41,"preClose":74.41,"latestTime":"19:13 EDT","volume":39037,"amount":2904746.17,"timestamp":1774653235681,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.566612,"impliedVol":0.2597,"impliedVolPercentile":0.9084},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":108366822,"roa":"2.37%","roe":"3.48%","lyrEps":1.77,"volumeRatio":0.566612,"shares":120028300,"dividePrice":3.081,"high":75.33,"amplitude":0.017473,"preClose":74.4,"low":74.03,"week52Low":68.98,"pbRate":"1.47","psRate":"12.43","week52High":82.08,"institutionHeld":0.9343,"latestPrice":74.41,"eps":1.77,"divideRate":0.041406,"volume":945681,"delay":0,"ttmEps":1.77,"open":74.4,"prevYearClose":72.03,"prevWeekClose":76.15,"prevMonthClose":80.48,"prevQuarterClose":72.03,"fiveDayClose":76.15,"twentyDayClose":80.48,"sixtyDayClose":72.84,"dividendPayoutRate":1.7363850728368737,"dividendFrequency":"M","dividendGrowthYears":10,"dividendGrowthRate":0.026999999999999986,"fiveYearAvgDividendRate":0.041531731300358074},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"ADC","amount":0.262,"announcedDate":"2026-03-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-31","defaultRemindTime":1774963800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-15","payableDate":"2026-03-31","currency":"USD","dateTimestamp":1774929600000,"payDate":"2026-04-15"},{"date":"2026-02-27","symbol":"ADC","amount":0.262,"announcedDate":"2026-02-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-27","defaultRemindTime":1772202600000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-13","payableDate":"2026-02-27","currency":"USD","dateTimestamp":1772168400000,"payDate":"2026-03-13"},{"date":"2026-02-10","symbol":"ADC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":1.07,"defaultRemindTime":1770757200000,"name":null,"time":"盘后","dateTimestamp":1770699600000,"actualEps":null},{"date":"2026-01-30","symbol":"ADC","amount":0.262,"announcedDate":"2026-01-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-30","defaultRemindTime":1769783400000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-13","payableDate":"2026-01-30","currency":"USD","dateTimestamp":1769749200000,"payDate":"2026-02-13"},{"date":"2025-12-31","symbol":"ADC","amount":0.262,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-15","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-15","value":0.465,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-15","value":0.48,"currency":"USD"},{"executeDate":"2016-09-28","recordDate":"2016-09-30","paymentDate":"2016-10-14","value":0.48,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2017-01-03","value":0.495,"currency":"USD"},{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-14","value":0.495,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.381,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.381,"analysts":21,"updateTime":1752206400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2026-03-27","current":42.039548,"percent":0.73127,"low":31.539495,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"high":53.261716,"avg":41.382341,"sd":4.476656,"marketCap":8915746245},"quantilePoints":[{"date":"2021-04-01","current":47.239256,"twenty":31.977009,"median":39.430911,"eighty":44.083322,"marketCap":4316770432},{"date":"2021-04-09","current":47.1005,"twenty":31.975443,"median":39.41667,"eighty":44.146464,"marketCap":4304090831},{"date":"2021-04-16","current":47.627771,"twenty":31.975443,"median":39.41667,"eighty":44.201737,"marketCap":4352273317},{"date":"2021-04-23","current":49.334461,"twenty":31.975443,"median":39.41667,"eighty":44.216631,"marketCap":4508232419},{"date":"2021-04-30","current":48.814129,"twenty":31.975443,"median":39.41667,"eighty":44.274005,"marketCap":4460683913},{"date":"2021-05-07","current":44.881383,"twenty":31.975443,"median":39.41667,"eighty":44.314742,"marketCap":4499986938},{"date":"2021-05-14","current":44.377456,"twenty":31.975443,"median":39.41667,"eighty":44.249425,"marketCap":4449461218},{"date":"2021-05-21","current":44.026621,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4414285084},{"date":"2021-05-28","current":44.830352,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4494870410},{"date":"2021-06-04","current":45.665977,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4578653566},{"date":"2021-06-11","current":45.646841,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4576734868},{"date":"2021-06-18","current":47.246871,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4737160278},{"date":"2021-06-25","current":48.748389,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4887708512},{"date":"2021-07-02","current":48.211648,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4833892628},{"date":"2021-07-09","current":49.210395,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4934031046},{"date":"2021-07-16","current":49.93058,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5006239701},{"date":"2021-07-23","current":50.956505,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5109102975},{"date":"2021-07-30","current":53.056971,"twenty":31.977009,"median":39.430911,"eighty":44.230599,"marketCap":5165308396},{"date":"2021-08-06","current":52.598062,"twenty":31.977009,"median":39.430911,"eighty":44.296692,"marketCap":5120631744},{"date":"2021-08-13","current":52.520401,"twenty":31.977009,"median":39.430911,"eighty":44.412506,"marketCap":5113071079},{"date":"2021-08-20","current":52.718085,"twenty":31.977009,"median":39.430911,"eighty":44.625208,"marketCap":5132316407},{"date":"2021-08-27","current":52.209754,"twenty":31.977009,"median":39.430911,"eighty":44.658936,"marketCap":5082828422},{"date":"2021-09-03","current":52.675724,"twenty":31.977009,"median":39.430911,"eighty":44.712504,"marketCap":5128192408},{"date":"2021-09-10","current":49.555141,"twenty":31.977009,"median":39.430911,"eighty":44.74795,"marketCap":4824391169},{"date":"2021-09-17","current":50.119952,"twenty":31.977009,"median":39.430911,"eighty":44.835833,"marketCap":4879377818},{"date":"2021-09-24","current":47.775985,"twenty":31.977009,"median":39.430911,"eighty":44.888065,"marketCap":4651183223},{"date":"2021-10-01","current":47.352376,"twenty":31.977009,"median":39.430911,"eighty":44.941549,"marketCap":4609943235},{"date":"2021-10-08","current":47.670083,"twenty":31.977009,"median":39.430911,"eighty":44.9864,"marketCap":4640873226},{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-23","current":42.755537,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8180587826},{"date":"2025-05-30","current":42.698147,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8169607171},{"date":"2025-06-06","current":42.411197,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8114703897},{"date":"2025-06-13","current":42.927706,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8213529790},{"date":"2025-06-20","current":43.220395,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8269531129},{"date":"2025-06-27","current":41.894687,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8015878004},{"date":"2025-07-03","current":41.30357,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7902777259},{"date":"2025-07-11","current":40.735409,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7794068777},{"date":"2025-07-18","current":41.234702,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7889600473},{"date":"2025-07-25","current":42.319373,"twenty":37.604201,"median":40.725789,"eighty":44.606841,"marketCap":8097134849},{"date":"2025-08-01","current":42.372392,"twenty":37.604201,"median":40.742491,"eighty":44.606841,"marketCap":7873129491},{"date":"2025-08-08","current":43.918584,"twenty":37.604201,"median":40.752858,"eighty":44.633348,"marketCap":8160424292},{"date":"2025-08-15","current":42.901923,"twenty":37.604201,"median":40.790693,"eighty":44.633348,"marketCap":7971520467},{"date":"2025-08-22","current":44.019656,"twenty":37.604201,"median":40.820493,"eighty":44.633348,"marketCap":8179204204},{"date":"2025-08-29","current":43.199192,"twenty":37.604201,"median":40.894276,"eighty":44.633348,"marketCap":8026755504},{"date":"2025-09-05","current":42.806797,"twenty":37.595885,"median":40.935905,"eighty":44.639951,"marketCap":7953845256},{"date":"2025-09-12","current":43.841294,"twenty":37.604201,"median":40.969944,"eighty":44.633348,"marketCap":8146063183},{"date":"2025-09-19","current":42.527363,"twenty":37.604201,"median":41.008406,"eighty":44.633348,"marketCap":7901924321},{"date":"2025-09-26","current":41.962551,"twenty":37.639342,"median":41.035693,"eighty":44.633348,"marketCap":7796977752},{"date":"2025-10-03","current":42.027951,"twenty":37.639342,"median":41.102705,"eighty":44.633348,"marketCap":7809129460},{"date":"2025-10-10","current":41.974442,"twenty":37.639342,"median":41.115788,"eighty":44.633348,"marketCap":7799187153},{"date":"2025-10-17","current":44.322871,"twenty":37.639342,"median":41.17126,"eighty":44.633348,"marketCap":8235543942},{"date":"2025-10-24","current":44.544295,"twenty":37.639342,"median":41.220151,"eighty":44.656944,"marketCap":8621592904},{"date":"2025-10-31","current":43.1986,"twenty":37.639342,"median":41.2516,"eighty":44.656944,"marketCap":8361132219},{"date":"2025-11-07","current":42.991114,"twenty":37.639342,"median":41.30357,"eighty":44.656944,"marketCap":8320973082},{"date":"2025-11-14","current":43.690638,"twenty":37.639342,"median":41.35326,"eighty":44.656944,"marketCap":8456366743},{"date":"2025-11-21","current":43.68471,"twenty":37.639342,"median":41.452784,"eighty":44.656944,"marketCap":8455219339},{"date":"2025-11-28","current":44.591721,"twenty":37.639342,"median":41.521652,"eighty":44.656944,"marketCap":8630772135},{"date":"2025-12-05","current":44.093754,"twenty":37.639342,"median":41.583569,"eighty":44.656944,"marketCap":8534390208},{"date":"2025-12-12","current":42.244164,"twenty":37.639342,"median":41.619337,"eighty":44.656944,"marketCap":8176400191},{"date":"2025-12-19","current":42.902191,"twenty":37.639342,"median":41.692355,"eighty":44.656944,"marketCap":8303762024},{"date":"2025-12-26","current":42.919976,"twenty":37.639342,"median":41.746748,"eighty":44.656944,"marketCap":8307204236},{"date":"2026-01-02","current":42.700633,"twenty":37.639342,"median":41.754028,"eighty":44.656944,"marketCap":8264750291},{"date":"2026-01-09","current":41.977396,"twenty":37.639342,"median":41.778924,"eighty":44.654358,"marketCap":8124767015},{"date":"2026-01-16","current":42.688777,"twenty":37.639342,"median":41.778924,"eighty":44.603089,"marketCap":8262455483},{"date":"2026-01-23","current":42.700633,"twenty":37.639342,"median":41.778924,"eighty":44.565186,"marketCap":8264750291},{"date":"2026-01-30","current":42.659136,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":8256718464},{"date":"2026-02-06","current":45.131184,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":8735185890},{"date":"2026-02-13","current":44.908403,"twenty":37.639342,"median":41.778924,"eighty":44.506847,"marketCap":9176987197},{"date":"2026-02-20","current":45.230936,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":9242896611},{"date":"2026-02-27","current":46.784962,"twenty":37.639342,"median":41.778924,"eighty":44.52786,"marketCap":9560460154},{"date":"2026-03-06","current":47.517993,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9710254277},{"date":"2026-03-13","current":46.714591,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9546079918},{"date":"2026-03-20","current":46.13403,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9427442972},{"date":"2026-03-27","current":43.629997,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":8915746245}],"updateTime":1774738087290},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584979211","title":"开发下一代 ADC，新锐融资1.2亿美元，默沙东支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2584979211","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584979211?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 22:12","pubTimestamp":1763561520,"startTime":"0","endTime":"0","summary":"Solve Therapeutics，一家开发实体瘤ADC药物的生物技术公司，宣布完成1.2亿美元超额认购融资，此轮融资由Yosemite领投，Alexandria Venture Investments、默沙东等多家机构参投，未提及财务顾问。该公司由行业资深领导者于2021年创立，已累计融资3.21亿美元。其核心技术CloakLink旨在增强ADC药物血浆稳定性，改善药代动力学，降低毒性。主要项目SLV-154和SLV-324正在进行I期临床试验，配备新诊断方法以实现精确患者选择。最新融资将用于加速临床管线和专有CloakLink连接子平台开发，支持两个项目的Ib期研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120014629a4ad5af9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120014629a4ad5af9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051811.HKD","LU1934455863.HKD","LU0266013472.USD","BK4534","SG9999002232.USD","BK4533","LU1974910355.USD","SGXZ57979304.SGD","BK4559","LU1929549753.HKD","LU2361045086.USD","LU0098860793.USD","MRK","LU1430594728.SGD","SG9999014567.USD","LU0320765646.SGD","LU1699723380.USD","LU0320765489.SGD","LU2361044865.SGD","LU0234572021.USD","LU0861579265.USD","IE0009355771.USD","SG9999014542.SGD","IE000M9KFDE8.USD","LU2112291526.USD","LU1941712348.USD","IE00BLSP4452.SGD","LU0208291251.USD","LU0203345920.USD","SG9999015358.SGD","SG9999015341.SGD","LU1066051225.USD","LU2023250843.SGD","LU0265550946.USD","LU0058720904.USD","BK4550","BK4588","LU1023059063.AUD","LU1989771016.USD","SG9999002224.SGD","IE00B2B36J28.USD","LU1917777945.USD","LU1035773651.USD","LU1585245621.USD","ADC","IE00BFTCPJ56.SGD","LU2361044949.HKD","LU1069347547.HKD","LU0211331839.USD","LU0070302665.USD"],"gpt_icon":0},{"id":"2584938632","title":"中国生物制药(01177)：LM-350“CDH17 ADC”临床试验申请获NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2584938632","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584938632?lang=zh_cn&edition=fundamental","pubTime":"2025-11-18 17:36","pubTimestamp":1763458582,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团全资附属公司礼新医药科技(上海)有限公司自主研发的国家1类创新药LM-350“CDH17抗体偶联药物”已获得中国国家药品监督管理局的临床试验批准。LM-350是基于礼新医药新一代LM-ADC平台开发的一款靶向CDH17的ADC，能够高度选择性地结合CDH17，具有很强的内化能力。LM-350采用IgG1野生型构型，同时具备抗体依赖细胞介导的细胞毒性作用活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","ADC","BK1589","BK1515","BK4080","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK4231","01177","BK1521","BK1191","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2584981992","title":"历史性突破！“中国智造”ADC新药全球首个取得食管癌III期临床研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2584981992","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584981992?lang=zh_cn&edition=fundamental","pubTime":"2025-11-18 15:37","pubTimestamp":1763451420,"startTime":"0","endTime":"0","summary":"2025年11月17日，由科创板头部企业百利天恒自主研发的全球首创、新概念双特异性抗体偶联药物药物iza-bren，在针对晚期食管鳞癌的III期临床试验达到无进展生存期和总生存期双主要终点。这是全球首个由ADC药物在食管癌治疗中取得双阳性结果的III期临床研究。　　在中国，每年有超过22万人被诊断患上食管癌，占到全球每年新发食管癌患者的一半左右，是食管癌患病人数和死亡人数最多的国家。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-18/doc-infxviex4517981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4080","III","ADC","BK4231","BK4134"],"gpt_icon":0},{"id":"2584606853","title":"攻克耗能黑洞，下一代AI硬件系统能耗锐减57.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584606853","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584606853?lang=zh_cn&edition=fundamental","pubTime":"2025-11-18 08:41","pubTimestamp":1763426497,"startTime":"0","endTime":"0","summary":"在先进的存算一体芯片中，ADC的能耗占比高达87.8%，面积占比高达75.2%，成为限制CIM芯片性能的关键因素。研究团队忆阻器ADC方案，通过存算一体化与忆阻器硬件创新，实现了AI硬件能耗锐减57.2%的技术突破。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/11/18084154249325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jrj_jhqb","symbols":["BK4110","BK4528","BK4080","BK4023","BK4587","ADC","BK4588","CIM","BK4585","BK4231","BK4551","BK4543"],"gpt_icon":1},{"id":"2584629325","title":"睿智医药发布全球首台ADC和核苷酸单体药物智造系统","url":"https://stock-news.laohu8.com/highlight/detail?id=2584629325","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584629325?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 21:40","pubTimestamp":1763386801,"startTime":"0","endTime":"0","summary":"11月17日，“超限·智造——ADC和核苷酸单体药物智造系统发布会”在上海张江举行。睿智医药联合华东师范大学推出全球首台适用于ADC与核苷酸亚磷酰胺单体合成的药物智造系统，为创新药产业高质量发展注入关键动能。据介绍，此次发布的ADC药物智造系统TAO-AG1采用微流控与AI智能控制技术，体积仅480×390×500mm，实现空间的高效利用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251117/31802762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300149","BK4231","BK4080","BK0216","BK0077","ADC"],"gpt_icon":0},{"id":"2583289945","title":"港股上市七个月，映恩生物启动回A计划 上半年亏逾20亿元，创始人高年薪受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2583289945","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583289945?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 11:33","pubTimestamp":1763091188,"startTime":"0","endTime":"0","summary":"在港股上市七个月后，映恩生物（证券简称：映恩生物-B；代码：09606）又拟回A股科创板上市。今年10月公司港交所公告称，公司拟发行将于上海证券交易所科创板上市并以人民币买卖的普通股。据证监会官网近日消息，映恩生物上周已正式启动上市辅导，中信证券担任辅导机构。官网资料显示，映恩生物是一家临床阶段的创新生物药企，专注于为癌症和自身免疫性疾病患者研发新一代抗体偶联药物（ADC）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143564657536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2583052383","title":"特朗普“降药价”新政下，中国药企谁是赢家？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583052383","media":"虎嗅APP","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583052383?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 07:55","pubTimestamp":1763078100,"startTime":"0","endTime":"0","summary":"特朗普此次力推的“最惠国定价”行政令，并非临时起意的价格管控，而是一套经过迭代的系统性政策工具，其核心目标是破解美国药价全球最高的沉疴。数据显示，2025年前三季度有30%的中小CDMO企业订单同比下滑超20%，主要集中在未获得头部跨国药企认证的企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656131051&idx=3&sn=307580111a03c35a6ac5ba41334e5264&chksm=670ddf7760681101ab50d42213fe9ed1ee00fa4c21859bf06f1c0999a7e9a1c11f10fd7ab67d&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["IE00B19Z3581.USD","LU1969619763.USD","LU1979443071.USD","BK4080","BK4550","BK4588","SG9999001176.USD","LU1883839398.USD","BK4007","06978","IE00BLSP4452.SGD","LU1066053197.SGD","LU2495084118.USD","BK4533","BK4568","BK4599","LU0306806265.USD","BK1161","LU1934453819.USD","LU1057294990.SGD","LU1023059063.AUD","LU0225771236.USD","SG9999002232.USD","LU0456842615.SGD","BK4231","LU1066051498.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU2488822045.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","603259","ADC","LU0170899867.USD","LU2328871848.SGD","LU1894683348.USD","LU1808992512.USD","BK1191","SG9999002224.SGD","SG9999003800.SGD","SG9999011175.SGD","IE00BBT3K403.USD","LU1997245094.SGD","06821","BK4592","SG9999001176.SGD","LU0289739699.SGD","BK4581","LU1997245177.USD"],"gpt_icon":1},{"id":"1195658704","title":"ADC Therapeutics 2025财年Q3业绩会总结及问答精华：ZENLATA临床进展与市场扩展潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1195658704","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195658704?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 22:21","pubTimestamp":1762784502,"startTime":"0","endTime":"0","summary":"ADC Therapeutics管理层强调ZENLATA在第三线以上DLBCL患者中的差异化治疗选择，并持续推进关键试验数据。管理层计划在2026年公布LOTUS V试验的顶线结果，并在2027年进行补充BLA提交。问题3：ZENLATA是否考虑进入DLBCL的一线治疗？ADC Therapeutics在2025财年第三季度通过降低运营成本和私募融资延长现金流，继续推进ZENLATA的临床试验和市场扩展。管理层对未来的市场潜力持乐观态度，预计ZENLATA将在DLBCL的第二线及以上治疗中实现显著的收入增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","ADC"],"gpt_icon":0},{"id":"2582848995","title":"【券商聚焦】中泰国际重申信达生物(01801)“买入”评级 指武田加盟将夯实公司在IO与ADC领域研发能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2582848995","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582848995?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 10:54","pubTimestamp":1762743250,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际研报指，信达生物 第三季度的产品销售收入同比增加40%以上至超33亿元人民币，略超预期。虽然肿瘤药达伯舒的第三季度销售额同比减少5.6%至1.4亿美元，但是由于新产品信尔美、信必乐与信必敏快速放量，除达伯舒以外的其他产品销售收入同比增加约八成。该机构指，公司日前与武田药品达成海外授权协议，将共同致力于肿瘤免疫疗法及抗体偶联物的研发。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969294","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","ADC"],"gpt_icon":0},{"id":"2582862418","title":"吉利德：Trop2 ADC一线治疗HR+/HER2-乳腺三期临床失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2582862418","media":"医药笔记","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582862418?lang=zh_cn&edition=fundamental","pubTime":"2025-11-08 09:31","pubTimestamp":1762565499,"startTime":"0","endTime":"0","summary":"▎Armstrong2025年11月7日，吉利德宣布Trop2 ADC新药Trodelvy对比化疗一线治疗内分泌治疗后HR+/HER2-乳腺癌的三期临床ASCENT-07没有达到PFS主要终点，关键次要终点OS尚未成熟，但观察到获益趋势，研究将继续进行以评估OS数据。Trodelvy一线治疗三阴乳腺癌已经递交上市申请。总结吉利德Trodelvy为全球首款Trop2 ADC，但作为上一代ADC在适应症拓展的道路上充满曲折，先后在非小细胞肺癌、尿路上皮癌失败，此次HR+/HER2-乳腺癌又错失PFS终点，仅守住三阴乳腺癌这一阵地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108093356a6e9fd53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108093356a6e9fd53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","BK4203","LU1585245621.USD","LU2324357040.USD","IE00B19Z3581.USD","LU1571399168.USD","LU0114720955.EUR","LU1674673428.USD","BK4532","LU1066053197.SGD","BK4566","SG9999015986.USD","HR","LU2087621335.USD","BK4588","IE00BKVL7J92.USD","LU0058720904.USD","LU1430594728.SGD","SG9999015945.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0109394709.USD","LU1839511570.USD","BK4578","LU0289739699.SGD","LU0320765992.SGD","LU1066051498.USD","BK4583","IE0002270589.USD","LU2468319806.SGD","LU0823416689.USD","LU1674673691.USD","BK4585","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4139","BK4225","LU0234570918.USD","LU1778281490.HKD","GILD","SG9999015978.USD","BK4080","BK4568","ADC","IE00B19Z3B42.SGD","LU0889565916.HKD","LU2089984988.USD","BK4231","SG9999015952.SGD","LU0882574055.USD"],"gpt_icon":0},{"id":"2581038400","title":"复宏汉霖PD-L1 ADC肺癌新药发布关键数据，CEO朱俊：定位PD-1 联用的super ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2581038400","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581038400?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 10:36","pubTimestamp":1762396614,"startTime":"0","endTime":"0","summary":"近日，HLX43肺癌关键数据更新发布，首次合并NSCLC II期国际多中心临床研究结果，全球临床价值持续验证。他表示，复宏汉霖至少会开8个III期临床项目，预计会包括两个一线，四个二线，以及两个三线，而这8个III期临床都会集中在肺癌。业内认为，复宏汉霖估值上行的关键在于其自研PD-L1抗体偶联药物HLX43的全球潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1762338933079134283","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["ADC","BK4023","LU1169590202.USD","02696","BK1161","LU1169589451.USD","BK4231","BK4080","PD"],"gpt_icon":1},{"id":"2581779683","title":"PD-L1 ADC肺癌数据积极 复宏汉霖HLX43迎关键节点与资金考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779683","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581779683?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 22:31","pubTimestamp":1762353115,"startTime":"0","endTime":"0","summary":"在近日举行的“2025国际肺癌前沿及创新论坛”上，复宏汉霖更新了HLX43在非小细胞肺癌（NSCLC）研究领域的关键数据。研究数据显示，不论是在鳞状还是非鳞状NSCLC，无论EGFR突变状态、是否伴有脑转移或PD-L1表达水平如何，HLX43均观察到疗效信号。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053556160251.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053556160251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1169589451.USD","BK4231","PD","BK1161","ADC","BK4023","LU1169590202.USD","02696","BK4080"],"gpt_icon":0},{"id":"2580678247","title":"百利天恒(688506.SH)：T-Bren(HER2 ADC)用于HER2阳性局部晚期或转移性胃或胃食管结合部腺癌患者纳入突破性治疗品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2580678247","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580678247?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 18:58","pubTimestamp":1762253926,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)公告，公司自主研发的创新生物药T-Bren(HER2 ADC)是一种靶向HER2的创新型ADC，具有同类最佳(Best-in-class)潜力，已在临床试验中展示出显著的抗肿瘤功效，其用于既往经一线抗HER2治疗及一线标准化疗方案治疗失败的HER2阳性局部晚期或转移性胃或胃食管结合部腺癌患者已被国家药品监督管理局药品审评中心纳入突破性治疗品种名单，近日已完成公示。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","BK0239","ADC","688506","02615","BK4080"],"gpt_icon":0},{"id":"2580059382","title":"全球肺癌治疗版图重构：本土创新药企凭ADC与双抗技术从“跟跑”转向“并跑”，复宏汉霖等公司国际化战略加速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2580059382","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580059382?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 13:43","pubTimestamp":1762234991,"startTime":"0","endTime":"0","summary":"黄浦江畔，一场关乎全球肺癌治疗未来的思想交锋正在上演。2025年11月2日，“开创未来·国际肺癌前沿及创新论坛”在上海召开，来自中、美等多国的顶尖肺癌专家齐聚一堂，直面肺癌长生存、治疗安全性及耐药性三大核心挑战。“靶向与免疫治疗已彻底重塑肺癌治疗版图，而ADC、双特异性抗体等新型疗法正在拓宽治疗边界。”大会主席、广东省人民医院吴一龙教授在开幕致辞中指出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511043554565469.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511043554565469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","06978","02696","BK4231","BK1574","ADC","BK4080"],"gpt_icon":0},{"id":"2580031902","title":"【券商聚焦】兴业证券维持翰森制药(03692)“买入”评级 指其ADC平台研发实力强","url":"https://stock-news.laohu8.com/highlight/detail?id=2580031902","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580031902?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 13:29","pubTimestamp":1762234153,"startTime":"0","endTime":"0","summary":"金吾财讯 | 兴业证券研报指出，翰森制药 于2025年10月16日与罗氏签订许可协议，公司将授予罗氏HS-20110的全球独占许可。截至目前，公司近3年已有5款产品分别与4家MNC达成了许可协议，数量在国内企业中领先。公司的 HS-20110 是第一款也是目前唯一一款与 MNC 达成许可协议的 CDH17ADC，能够在如此激烈的竞争中脱颖而出，说明公司 ADC 平台研发实力强，能够持续推出优质 ADC 管线。对应2025年10月31日收盘价，PE分别为44.92x、42.38x、35.84x，维持“买入”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1968993","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601377","03692","ADC"],"gpt_icon":0},{"id":"2580501002","title":"【券商聚焦】信达证券首予维立志博(09887)“买入”评级 指ADC平台未来可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2580501002","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580501002?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 13:18","pubTimestamp":1762147106,"startTime":"0","endTime":"0","summary":"金吾财讯 | 信达证券研报指出，维立志博 是国内稀缺的同时具备IO2.0+ADC2.0平台的Biotech，在IO联合ADC的大背景下，公司构建的新一代++成为其核心竞争力，基于三大技术平台全面布局 IO2.0、TCE、ADC 三大业界公认的肿瘤治疗前沿技术方向，全方位、多手段攻克肿瘤治疗难题。LBL-024 联合化疗一线治疗肺外神经内分泌癌、一线治疗小细胞肺癌均表现出了“Bestin-Class”竞争力，显著优于现有 SOC。LBL-024 单药治疗有望填补肺外神经内分泌癌末线治疗的空白。ADC平台未来可期。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1968896","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601059","09887","ADC"],"gpt_icon":0},{"id":"2580840148","title":"海峡西岸概念再度上演涨停潮：下周机会如何把握？","url":"https://stock-news.laohu8.com/highlight/detail?id=2580840148","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580840148?lang=zh_cn&edition=fundamental","pubTime":"2025-11-02 13:00","pubTimestamp":1762059600,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　平潭发展和海峡创新作为海峡西岸概念此轮行情的领涨龙头，本周股价涨幅分别高达56%和60%，表明平潭概念股是海峡西岸概念整个板块的领涨核心方向。　　从海峡西岸城市群的基本情况和潜力来看，其有望成为中国的第四大经济极。2014年12月，平潭列入新一轮自由贸易区建设试点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/jsy/2025-11-02/doc-infvyuyv2132097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2106854487.HKD","SG9999002224.SGD","BK4554","LU1917777945.USD","LU0942090050.USD","BK4588","BK4231","SG9999001424.SGD","SINA","BK4573","ADC","BK4581","BK4612","LU1244550221.USD","LU1244550577.SGD","SG9999015952.SGD","LU0061475181.USD","LU1084165304.USD","BK4575","LU0868494617.USD","BK4561","LU1974910355.USD","IE00BSNM7G36.USD","LU1496350502.SGD","LU0081259029.USD","LU1261432733.SGD","SG9999015978.USD","BK4605","IE00BVYPNQ40.USD","LU1035775433.USD","BK4532","BK4515","GB00BDT5M118.USD","BK4512","SG9999015986.USD","BK4604","IE00BGHQDM52.EUR","LU1244550494.USD","SG9999015945.SGD","LU0868494708.USD","LU2247934214.USD","BK4579","BK4585","BK4598","IE00BVYPNP33.GBP","LU2023250504.SGD","SG9999002232.USD","BK4141","BK4527"],"gpt_icon":1},{"id":"2579546060","title":"新股消息 | 百力司康拟港股上市 中国证监会要求补充说明公司经营管理的实际运作等情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2579546060","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579546060?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 21:43","pubTimestamp":1761918193,"startTime":"0","endTime":"0","summary":"在公示中，证监会要求百力司康补充说明公司经营管理的实际运作、对经营管理团队施加重大影响等情况。据港交所6月29日披露，BlissBio Inc.向港交所主板递交上市申请，高盛、华泰国际及建银国际为联席保荐人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4190","BK4080","BK4231","ADC","BC"],"gpt_icon":0},{"id":"2579443756","title":"高盛：下一代IO-ADC有望引领复宏汉霖(02696)全球化管线布局 首予“买入”评级 目标价100.70港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579443756","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579443756?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 15:24","pubTimestamp":1761895484,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，高盛发布研报称，复宏汉霖下一代IO-ADC将引领其全球化管线布局，首予该股“买入”评级，12个月目标价为100.70港元。这一目标价较该股周四收盘价66.10港元有52.3%的上行空间。高盛表示，复宏汉霖正战略性地从生物类似药领域的早期先行者，转型为全球创新型生物制药公司。高盛认为，随着未来6至12个月内催化剂事件密集，复宏汉霖当前估值具有吸引力，首次覆盖并给予 “买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADC","02696"],"gpt_icon":0},{"id":"2579305504","title":"身价超越宗馥莉，中国新晋女首富什么来头？","url":"https://stock-news.laohu8.com/highlight/detail?id=2579305504","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579305504?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 14:30","pubTimestamp":1761892207,"startTime":"0","endTime":"0","summary":"10月30日，胡润研究院发布的《2025胡润女企业家榜》显示，来自中国创新药头部企业翰森的64岁钟慧娟以1410亿元财富首次成为中国女首富，这是胡润女企业家榜二十年来的第八位新晋榜首，同时也是榜单史上第一位从事生命健康领域的女首富。截至今年上半年，公司在中国产生销售收入的创新药共有7款。钟慧娟与女儿孙远合计持有翰森制药股权比例超过60%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://finance.ifeng.com/c/8ntqSASyMqE","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.ifeng.com/c/8ntqSASyMqE","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["09939","BK4080","BK1191","03692","BK1161","06978","BK1589","BK1574","BK1515","BK4231","BK1583","ADC"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":136,"code":"91000000","status":"200"}]}}